BIOL stock forecast
Our latest prediction for BIOLASE, Inc.'s stock price was made on the June 25, 2019 when the stock price was at 1.46$.
In the short term (2weeks), BIOL's stock price should underperform the market by -0.44%. During that period the price should oscillate between -11.25% and +17.91%.
In the medium term (3months), BIOL's stock price should outperform the market by 7.76%. During that period the price should oscillate between -23.26% and +50.85%.Get email alerts
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company, which engages in the development, manufacture, market and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA.
At the moment the company generates 43M USD in revenues.
On its last earning announcement, the company reported a loss of -0.98$ per share.
The book value per share is 0.99$
Three months stock forecastJune 25, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|